4.6 (269) · $ 6.99 · In stock
Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…
Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Current Strategies of Muscular Dystrophy Therapeutics: An Overview
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
muscle stem cells, The Stem Cellar
Promising disease modifying approach to Duchenne muscular
Frontiers Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells
Duchenne Muscular Dystrophy Therapeutics Market Outlook, Size, Prominent Players, Share, Challenges and Forecast 2028
Regenerative Rehabilitation for Duchenne Muscular Dystrophy
Sanford Burnham Prebys Medical Discovery Institute
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy